Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0N2RJ
|
|||
| Former ID |
DNC010037
|
|||
| Drug Name |
1-(2-(3-fluorophenoxy)phenyl)piperazine
|
|||
| Synonyms |
CHEMBL573973; 1-(2-(3-fluorophenoxy)phenyl)piperazine
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C16H17FN2O
|
|||
| Canonical SMILES |
C1CN(CCN1)C2=CC=CC=C2OC3=CC(=CC=C3)F
|
|||
| InChI |
1S/C16H17FN2O/c17-13-4-3-5-14(12-13)20-16-7-2-1-6-15(16)19-10-8-18-9-11-19/h1-7,12,18H,8-11H2
|
|||
| InChIKey |
ZTEDPRVVBLHAKJ-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1... Bioorg Med Chem Lett. 2009 Dec 1;19(23):6604-7. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.